Valuation: OptimizeRx Corporation

Market Cap 171M 153M 141M 128M 240M 16.25B 243M 1.7B 673M 8.5B 641M 628M 26.92B P/E 2026 *
40.6x
P/E 2027 * 20.8x
Enterprise Value 171M 153M 141M 128M 240M 16.25B 243M 1.7B 673M 8.5B 641M 628M 26.92B EV / Sales 2026 *
1.78x
EV / Sales 2027 * 1.6x
Free-Float
78.89%
Yield 2026 *
-
Yield 2027 * -
1 day-0.87%
1 week+3.78%
Current month+8.62%
1 month+12.81%
3 months+45.35%
6 months+41.06%
Current year-26.02%
1 week 8.56
Extreme 8.555
9.6
1 month 7.69
Extreme 7.69
9.6
Current year 4.54
Extreme 4.54
14.16
1 year 4.54
Extreme 4.54
21.56
3 years 3.78
Extreme 3.78
22.25
5 years 3.78
Extreme 3.78
99.18
10 years 1.89
Extreme 1.890018
99.18
Manager TitleAgeSince
Chief Executive Officer 48 2024-12-30
Director of Finance/CFO 60 2021-10-10
Chief Operating Officer - 2025-08-17
Director TitleAgeSince
Director/Board Member 61 2017-01-11
Chairman 70 2024-01-23
Director/Board Member 70 2018-03-26
Date Insider Type Main position Quantity % Market Cap. Importance
10/1/26 Tax

Investor Relations Manager

-414 0.0022%
9/1/26 Tax

Investor Relations Manager

-1,432 0.0076%
8/21/26 Tax

Investor Relations Manager

-1,243 0.0066%
Change 5-day change 1-year change 3-year change Capi.($)
-0.87%+3.78%-58.16%+14.66% 172M
-1.06%-7.96%+21.88%+159.08% 3,900B
-1.88%-10.61%-14.60%+118.68% 1,643B
-1.62%-0.47%+6.94%+68.27% 546B
+0.31%-5.56%-40.91%+32.38% 443B
-2.96%-8.52%-41.63%+58.35% 270B
+0.61%-7.66%-42.62%+21.50% 248B
-0.30%-1.68%-2.76%+260.21% 217B
-0.85%-5.47%-29.70%+62.80% 136B
-2.03%+10.33%-11.37%+261.38% 120B
Average -0.60%-3.59%-21.29%+105.73% 752.33B
Weighted average by Cap. -0.47%-7.47%+2.55%+130.86%

Financials

2026 *2027 *
Net sales 96.23M 86.05M 79.61M 72.08M 135M 9.16B 137M 958M 379M 4.79B 361M 353M 15.16B 107M 95.32M 88.19M 79.85M 149M 10.14B 152M 1.06B 420M 5.3B 400M 392M 16.8B
Net income 4.92M 4.4M 4.07M 3.68M 6.89M 468M 7M 48.94M 19.36M 245M 18.45M 18.06M 775M 8.9M 7.96M 7.37M 6.67M 12.48M 847M 12.69M 88.64M 35.06M 443M 33.42M 32.7M 1.4B
Net Debt - -
Projected Income Statement - Annual - OptimizeRx Corporation
Logo OptimizeRx Corporation
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
Employees
133
Date Price Change Volume
26-10-26 US$9.070 -0.87% 141,836
26-10-23 US$9.150 +0.77% 77,100
26-10-22 US$9.080 -3.09% 134,281
26-10-21 US$9.370 +4.93% 187,047
26-10-20 US$8.930 +2.17% 157,746
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - OptimizeRx Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
9.070USD
Average target price
12.60USD
Spread / Average Target
+38.92%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - OptimizeRx Corporation
  1. Stock Market
  2. Stocks
  3. OPRX Stock